The inconsistent results regarding the IL-21 levels and their association with disease activity may be attributed to the heterogeneity in the clinical features of patients with SLE, including the disease evolution, level of disease activity, as well as different stratifications of disease activity indices. The gene discussed is IL21; the disease is systemic lupus erythematosus.